HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCR-15: International Cosmetics Regulator Group Tackles Consumer Safety Perceptions

Executive Summary

The International Cooperation on Cosmetics Regulations continues efforts to minimize barriers to international trade through regulatory convergence, while also taking steps to educate consumers on cosmetics safety issues that may be widely misunderstood. Personal Care Products Council leadership discusses developments from the regulator group’s 15th annual meeting in June.

You may also be interested in...



US FDA Convinced: Cosmetic Adverse Event Reports Aren’t Telling Whole Story

Linda Katz, director of the FDA’s cosmetics office, says to “stay tuned” for federal legislative developments in 2022, maintaining her position that voluntary adverse-event reporting paints an incomplete picture of consumers’ experience with cosmetic products across the US.

DECIEM Analyzes Billions Of Google Searches To Tackle Cosmetic Ingredient ‘Misconceptions’

The Estee Lauder Companies’ outfit breaks down the cosmetic safety assessment process, the science of skin inflammation and sensitivity, and safe and effective use of highly searched ingredients including zinc, hyaluronic acid and retinol in a September report aimed at bringing clarity to conversations online.

Cosmetic Brands, And Animals, Have Growing Problem In Europe; Commission’s Nanomaterials Report

The European Commission’s Scientific Committee for Consumer Safety has been unable to get the data it needs to properly assess the safety of nanomaterials in cosmetic products. The European Commission expects REACH to address the issue, and that is probably not a prospect that industry stakeholders relish.

Related Content

Topics

UsernamePublicRestriction

Register

RS151701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel